tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

PCVX Stock Latest News

Vaxcyte Earnings Call: Cash Strength, Trials Accelerate
Company AnnouncementsVaxcyte Earnings Call: Cash Strength, Trials Accelerate
9d ago
PCVX
Regulatory Timing Risks: How FDA Delays Could Derail Vaxcyte’s Development and Commercialization Plans
PremiumCompany Announcements
Regulatory Timing Risks: How FDA Delays Could Derail Vaxcyte’s Development and Commercialization Plans
13d ago
PCVX
Vaxcyte: Buy Rated on Superior VAX-31 Coverage, Robust Phase 3 OPUS Program, and Strong Cash Runway Through 2028
PremiumRatings
Vaxcyte: Buy Rated on Superior VAX-31 Coverage, Robust Phase 3 OPUS Program, and Strong Cash Runway Through 2028
14d ago
PCVX
Vaxcyte price target raised to $89 from $85 at BTIG
PremiumThe Fly
Vaxcyte price target raised to $89 from $85 at BTIG
14d ago
PCVX
Vaxcyte price target lowered to $133 from $134 at BofA
PremiumThe Fly
Vaxcyte price target lowered to $133 from $134 at BofA
14d ago
PCVX
Vaxcyte price target raised to $67 from $38 at Goldman Sachs
PremiumThe FlyVaxcyte price target raised to $67 from $38 at Goldman Sachs
14d ago
PCVX
Vaxcyte price target raised to $75 from $50 at TD Cowen
Premium
The Fly
Vaxcyte price target raised to $75 from $50 at TD Cowen
14d ago
PCVX
Vaxcyte Launches New $500 Million ATM Equity Program
Premium
Company Announcements
Vaxcyte Launches New $500 Million ATM Equity Program
15d ago
8K
PCVX
Vaxcyte reports Q4 EPS ($5.63) vs ($3.80) last year
PremiumThe Fly
Vaxcyte reports Q4 EPS ($5.63) vs ($3.80) last year
15d ago
PCVX
Is PCVX a Buy, Before Earnings?
PremiumPre-Earnings
Is PCVX a Buy, Before Earnings?
17d ago
PCVX
Vaxcyte’s VAX-31 Moves Into Phase 3: What This Pneumococcal Vaccine Update Means for PCVX Investors
PremiumCompany Announcements
Vaxcyte’s VAX-31 Moves Into Phase 3: What This Pneumococcal Vaccine Update Means for PCVX Investors
19d ago
PCVX
Vaxcyte doses first participants in OPUS-3 trial
PremiumThe Fly
Vaxcyte doses first participants in OPUS-3 trial
28d ago
PCVX
Vaxcyte Completes Public Equity Offering, Bolstering Capital Position
PremiumCompany AnnouncementsVaxcyte Completes Public Equity Offering, Bolstering Capital Position
1M ago
8K
PCVX
Vaxcyte 11M share Spot Secondary priced at $50.00
Premium
The Fly
Vaxcyte 11M share Spot Secondary priced at $50.00
1M ago
PCVX
Vaxcyte secondary being re-offered at $50 per share
Premium
The Fly
Vaxcyte secondary being re-offered at $50 per share
1M ago
PCVX
Vaxcyte offering marketed at $50 per share, Bloomberg says
PremiumThe Fly
Vaxcyte offering marketed at $50 per share, Bloomberg says
1M ago
PCVX
Vaxcyte announces offering of $500M of common stock and warrants
PremiumThe Fly
Vaxcyte announces offering of $500M of common stock and warrants
1M ago
PCVX
Vaxcyte provides update on development of VAX-31 pneumococcal vaccine
PremiumThe Fly
Vaxcyte provides update on development of VAX-31 pneumococcal vaccine
2M ago
PCVX
Needham ups Vaxcyte target, adds to Conviction List
PremiumThe Fly
Needham ups Vaxcyte target, adds to Conviction List
2M ago
PCVX
PHAT
Buy Rating on Vaxcyte: De-Risked VAX-31 Clinical Profile, Strong Cash Position, and Attractive Entry Ahead of 2026 Phase 3 Catalyst
PremiumRatingsBuy Rating on Vaxcyte: De-Risked VAX-31 Clinical Profile, Strong Cash Position, and Attractive Entry Ahead of 2026 Phase 3 Catalyst
2M ago
PCVX
Mizuho positive on Vaxcyte after HHS maintains PCV schedule for children
Premium
The Fly
Mizuho positive on Vaxcyte after HHS maintains PCV schedule for children
2M ago
PCVX
Vaxcyte Enhances Executive Severance to Align With Market
Premium
Company Announcements
Vaxcyte Enhances Executive Severance to Align With Market
3M ago
8K
PCVX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >